These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4072874)

  • 1. Comparative efficacy and safety of short-acting and sustained release quinidine in the treatment of patients with ventricular arrhythmias.
    Morganroth J; Hunter H
    Am Heart J; 1985 Dec; 110(6):1176-81. PubMed ID: 4072874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
    Wasty N; Saksena S; Barr MJ
    Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    Am J Cardiol; 1985 Jul; 56(1):84-8. PubMed ID: 4014046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of intravenous quinidine.
    Swerdlow CD; Yu JO; Jacobson E; Mann S; Winkle RA; Griffin JC; Ross DL; Mason JW
    Am J Med; 1983 Jul; 75(1):36-42. PubMed ID: 6859083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1985 Oct; 56(10):585-7. PubMed ID: 3901720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias.
    Panidis I; Morganroth J
    J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability study of three sustained release quinidine formulations.
    Mahon WA; Leeder JS; Brill-Edwards MM; Correia J; MacLeod SM
    Clin Pharmacokinet; 1987 Aug; 13(2):118-24. PubMed ID: 3621768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis.
    Morganroth J; Goin JE
    Circulation; 1991 Nov; 84(5):1977-83. PubMed ID: 1834365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical evaluation of two salts of quinidine using 24-hour Holter monitor recordings.
    Thompson EJ; Marwaha R; Naik G
    Angiology; 1978 Mar; 29(3):251-9. PubMed ID: 77140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.